(Total Views: 1243)
Posted On: 02/25/2022 11:40:33 PM
Post# of 153930
Ohm,
Concerning Advanced Genetic Technologies, you are correct. I saw this in a 10-K from 2020 (it may be in more recent ones also - I did not check):
Note 2 – Summary of Significant Accounting Policies
Principles of Consolidation
The consolidated financial statements include the accounts of CytoDyn Inc. and its wholly owned subsidiaries, CytoDyn Operations Inc., Advanced Genetic Technologies, Inc. (“AGTI”) and CytoDyn Veterinary Medicine LLC (“CVM”), of which both AGTI and CVM are dormant entities. All intercompany transactions and balances are eliminated in consolidation.
Concerning Advanced Genetic Technologies, you are correct. I saw this in a 10-K from 2020 (it may be in more recent ones also - I did not check):
Note 2 – Summary of Significant Accounting Policies
Principles of Consolidation
The consolidated financial statements include the accounts of CytoDyn Inc. and its wholly owned subsidiaries, CytoDyn Operations Inc., Advanced Genetic Technologies, Inc. (“AGTI”) and CytoDyn Veterinary Medicine LLC (“CVM”), of which both AGTI and CVM are dormant entities. All intercompany transactions and balances are eliminated in consolidation.
(2)
(0)
